コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 tests (FITs) for hemoglobin (Hb) are used in colorectal cancer screening.
2 from a research tool to a viable option for colorectal cancer screening.
3 he proportion of available capacity used for colorectal cancer screening.
4 portions of available capacity were used for colorectal cancer screening.
5 knowledge, attitudes, and beliefs regarding colorectal cancer screening.
6 y or colonoscopy may contribute to deficient colorectal cancer screening.
7 rostate cancer screening is more common than colorectal cancer screening.
8 ound to carry the mutation received lifelong colorectal cancer screening.
9 alone cannot be considered a substitute for colorectal cancer screening.
10 stinal cancers this year were in the area of colorectal cancer screening.
11 is expanding, increasing the availability of colorectal cancer screening.
12 t ages at which specific groups should begin colorectal cancer screening.
13 and magnetic resonance (MR) colonography-for colorectal cancer screening.
14 conomic approaches could increase uptake for colorectal cancer screening.
15 cer mortality demonstrate an urgent need for colorectal cancer screening.
16 e colonoscopy increases uptake of endoscopic colorectal cancer screening.
17 There are many test options available for colorectal cancer screening.
18 e needed to establish their role for general colorectal cancer screening.
19 o inform their update of recommendations for colorectal cancer screening.
20 of patients undergoing breast, cervical, and colorectal cancer screening.
21 irtual colonoscopy, and fecal DNA testing in colorectal cancer screening.
22 y colonography is a promising new method for colorectal cancer screening.
23 e performance of nonendoscopic approaches to colorectal cancer screening.
24 the intervention firm attended a workshop on colorectal cancer screening.
25 e clear potential to increase compliance for colorectal cancer screening.
26 e of the largest contributors to the cost of colorectal cancer screening.
27 sive test could improve the effectiveness of colorectal-cancer screening.
28 creening would be less common among men than colorectal cancer screening, a preventive service of bro
29 on of mammography, Papanicolaou testing, and colorectal cancer screening according to U.S. Preventive
30 ents with diabetes, chlamydia screening, and colorectal cancer screening (adjusted P < 0.05 for each)
35 stimates of the current number of endoscopic colorectal cancer screening and follow-up examinations b
36 d video had no effect on the overall rate of colorectal cancer screening and only modestly improved s
37 munochemical test (FIT) is commonly used for colorectal cancer screening and positive test results re
39 tion arm attended an educational workshop on colorectal cancer screening and received confidential fe
42 are aware of the known mortality benefit of colorectal cancer screening and the uncertain benefits o
43 ged to ensure that eligible patients undergo colorectal cancer screening and to guide patients in cho
46 olorectal cancer or polyps, had not received colorectal cancer screening, and had at least one visit
47 riety of noninvasive molecular approaches to colorectal cancer screening are emerging with potential
51 om 327,785 average-risk adults who underwent colorectal cancer screening at 84 gastrointestinal pract
53 nfluenza vaccination, cholesterol screening, colorectal cancer screening, bone densitometry, and mamm
54 ination can be a cost-effective component of colorectal cancer screening, but further modeling effort
55 e studies reaffirm the cost-effectiveness of colorectal cancer screening, but illustrate that aspirin
58 d for the study from a teaching hospital and colorectal cancer screening centre between 2003 and 2011
59 ificantly increased both recommendations and colorectal cancer screening completion rates among veter
60 psies) and 11 healthy individuals undergoing colorectal cancer screening (controls), collected during
62 ive Services Task Force (USPSTF) recommended colorectal cancer screening for adults 50 years of age o
65 nd the American Geriatrics Society recommend colorectal cancer screening for older adults unless they
70 e on prostate cancer screening compared with colorectal cancer screening in 27 states, while up-to-da
71 ination has been recognized as an option for colorectal cancer screening in Americans with average ri
72 rast barium enema examinations performed for colorectal cancer screening in average-risk adults older
73 methods are recommended equally strongly for colorectal cancer screening in average-risk persons.
74 ance measures included breast, cervical, and colorectal cancer screening in eligible patients; hemogl
77 CT colonography as the major imaging test in colorectal cancer screening in the United States, with M
79 al testing (FIT) are accepted strategies for colorectal-cancer screening in the average-risk populati
80 ws the current status and future outlook for colorectal cancer screening, including a discussion of r
81 er screening increased in 8 of 48 states and colorectal cancer screening increased in 13 of 49 states
82 ompare the cost-effectiveness of two 35-year colorectal cancer screening interventions among Asians,
91 he proportion of available capacity used for colorectal cancer screening, it could take up to 10 year
92 s with limited life expectancy, the risks of colorectal cancer screening may outweigh the benefits.
94 preferences against screening, the risks of colorectal cancer screening outweigh the benefits, and t
97 a screening colonoscopy within the National Colorectal Cancer Screening Program in Poland, from Janu
98 included in the first round of the Barcelona colorectal cancer screening program, from December 2009
99 France (age, 50-74 y) who participated in a colorectal cancer screening program, from June 2009 thro
100 went screening colonoscopy within a National Colorectal Cancer Screening Program, we associated incre
105 echanical CT analysis of CT colonography for colorectal cancer screening provides a comprehensive ost
107 erly feedback reports to physicians improved colorectal cancer screening rates at a VA medical center
108 ly feedback to physicians on their patients' colorectal cancer screening rates led to a 9% increase i
115 iation oncologists who traditionally provide colorectal cancer screening services and treatment.
116 ing participation of deprived individuals in colorectal cancer screening should be directed at all st
117 ished estimates of cost and effectiveness of colorectal cancer screening strategies, and the directio
120 vance has numerous potential applications in colorectal cancer screening such as improved polyp detec
126 Eligible studies reported performance of colorectal cancer screening tests or health outcomes in
129 e expectancies may receive less benefit from colorectal cancer screening than younger, healthier pati
130 en validated as an effective tool for use in colorectal cancer screening that is increasingly being d
131 ncer prevention services ranged from 51% for colorectal cancer screening to 88% for cervical cancer s
132 estimate of the national capacity to provide colorectal cancer screening to all eligible persons in t
133 ting for celiac disease, and age-appropriate colorectal cancer screening) to exclude organic diseases
134 stematic review of the cost-effectiveness of colorectal cancer screening, to illustrate key methodolo
136 cer screening in 27 states, while up-to-date colorectal cancer screening was more common in only 1 st
140 ients at higher-than-average risk undergoing colorectal cancer screening were consecutively recruited
141 ears and older, who had not undergone recent colorectal cancer screening, were surveyed about their k
142 to change their use of breast, cervical, and colorectal cancer screening when tests were fully covere
143 ide a high-throughput method for noninvasive colorectal cancer screening when used in conjunction wit
144 Advancing age was inversely associated with colorectal cancer screening, whereas comorbidity was a w
145 ssioned a study on the cost-effectiveness of colorectal cancer screening, which revealed that screeni
146 d a case-control study in 822 men undergoing colorectal cancer screening who were recruited to also u
147 of advanced histology in patients undergoing colorectal cancer screening whose largest polyp is 9 mm
149 tients aged 50 through 70 years eligible for colorectal cancer screening with a positive FIT result w
152 olled asymptomatic adults undergoing routine colorectal cancer screening with CT colonography at two
156 ecommended by professional organizations for colorectal cancer screening, yet the rates of colorectal
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。